Aortic stenosis, affecting nine million people globally, is often unnoticed as symptoms are mistaken for aging. This heart ...

Patients with low-gradient aortic stenosis and reduced LVEF, compared with patients with high-gradient aortic stenosis, have worse clinical outcomes.

The Navitor Vision, Abbott's latest TAVI system, is designed to improve accuracy during implantation and enhance visibility ...

Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality.

The Journal of the San Juan Islands relies on subscription revenue to provide local content for our readers.

GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...

Aims Exercise testing remains underused in patients with aortic stenosis (AS), partly due to concerns about an ...

SGMC Health recently achieved the successful completion of its first transcarotid access Transcatheter Aortic Valve ...

These latest data reinforce years of smaller studies, but whether they should change practice is a matter of debate.

Navitor Vision enhances visibility and precision in TAVI procedures, offering a less invasive alternative to surgical aortic ...

The US Food and Drugs Administration (FDA) is expected to approve the JenaValve Trilogy System, a transcatheter aortic valve ...

A 94-year-old great-grandmother from South Mumbai underwent a transcatheter aortic valve replacement (TAVR) to treat her breathlessness caused by aort ...